Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody
Identifieur interne : 001E75 ( Main/Merge ); précédent : 001E74; suivant : 001E76Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody
Auteurs : Katsuya Morishita [Japon] ; Shinobu Wakamoto [Japon] ; Toru Miyazaki [Japon] ; Shinichiro Sato [Japon] ; Mitsuhiro Fujihara [Japon] ; Sadao Kaneko [Japon] ; Hiroshi Yasuda [Japon] ; Sadamitsu Yamamoto [Japon] ; Hiroshi Azuma [Japon] ; Toshiaki Kato [Japon] ; Hisami Ikeda [Japon]Source :
- Transfusion [ 0041-1132 ] ; 2005-05.
English descriptors
- Teeft :
- Adverse effects, Adverse reaction, Adverse reactions, Aggregation, Blood center, Blood components, Blood products, Blood recipients, Blood transfusion, Brain surgery, Case report, Cutaneous manifestation, Cytometric, Flow cytometric analysis, Glycoprotein, Healthy adults, Hiroshi azuma, Ikeda, Isoantibody, Moab, Monocyte, Naka, Negative control, Passive transfusion, Plasma protein, Platelet, Platelet membrane glycoprotein, Plts, Posttransfusion, Posttransfusion syndrome, Rantes, Systolic blood pressure, Thrombocytopenia, Transfusion, Transfusion volume.
Abstract
BACKGROUND: Anti‐CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura–like syndrome. There are few reports, however, about the effects of passively transfused blood products containing this isoantibody on recipients. CASE REPORT: A 67‐year‐old Japanese woman underwent brain surgery. On the 6th postoperative day, the patient experienced tightness of the chest and nausea after receiving a transfusion of fresh frozen plasma (FFP). When she manifested hypotension, the transfusion was discontinued. No cutaneous manifestation was observed. The patient's condition gradually improved soon after the administration of steroids. RESULTS: Her pretransfusion PLT count was 17.1 × 104 per µL. It decreased to 1.9 × 104 per µL 12 hours after transfusion and recovered to 15.4 × 104 per µL 8 days after transfusion. The donor of the FFP had a Type I CD36 deficiency. Flow cytometric analysis identified anti‐CD36 isoantibody in the FFP. The cross‐match between the patient's PLTs and the FFP was positive. The FFP induced the aggregation of PLTs derived from healthy adults. CONCLUSION: This is the first reported case of life‐threatening adverse effects and thrombocytopenia caused by passively transfused anti‐CD36 isoantibody. The possibility of passive infusion of this antibody should be considered in the evaluation of life‐threatening transfusion reactions followed by thrombocytopenia.
Url:
DOI: 10.1111/j.1537-2995.2005.04320.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002A65
- to stream Istex, to step Curation: 002A65
- to stream Istex, to step Checkpoint: 000D11
Links to Exploration step
ISTEX:1561F0D665871531FCF0027DC6D3353D8954A606Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title>
<author><name sortKey="Morishita, Katsuya" sort="Morishita, Katsuya" uniqKey="Morishita K" first="Katsuya" last="Morishita">Katsuya Morishita</name>
</author>
<author><name sortKey="Wakamoto, Shinobu" sort="Wakamoto, Shinobu" uniqKey="Wakamoto S" first="Shinobu" last="Wakamoto">Shinobu Wakamoto</name>
</author>
<author><name sortKey="Miyazaki, Toru" sort="Miyazaki, Toru" uniqKey="Miyazaki T" first="Toru" last="Miyazaki">Toru Miyazaki</name>
</author>
<author><name sortKey="Sato, Shinichiro" sort="Sato, Shinichiro" uniqKey="Sato S" first="Shinichiro" last="Sato">Shinichiro Sato</name>
</author>
<author><name sortKey="Fujihara, Mitsuhiro" sort="Fujihara, Mitsuhiro" uniqKey="Fujihara M" first="Mitsuhiro" last="Fujihara">Mitsuhiro Fujihara</name>
</author>
<author><name sortKey="Kaneko, Sadao" sort="Kaneko, Sadao" uniqKey="Kaneko S" first="Sadao" last="Kaneko">Sadao Kaneko</name>
</author>
<author><name sortKey="Yasuda, Hiroshi" sort="Yasuda, Hiroshi" uniqKey="Yasuda H" first="Hiroshi" last="Yasuda">Hiroshi Yasuda</name>
</author>
<author><name sortKey="Yamamoto, Sadamitsu" sort="Yamamoto, Sadamitsu" uniqKey="Yamamoto S" first="Sadamitsu" last="Yamamoto">Sadamitsu Yamamoto</name>
</author>
<author><name sortKey="Azuma, Hiroshi" sort="Azuma, Hiroshi" uniqKey="Azuma H" first="Hiroshi" last="Azuma">Hiroshi Azuma</name>
</author>
<author><name sortKey="Kato, Toshiaki" sort="Kato, Toshiaki" uniqKey="Kato T" first="Toshiaki" last="Kato">Toshiaki Kato</name>
</author>
<author><name sortKey="Ikeda, Hisami" sort="Ikeda, Hisami" uniqKey="Ikeda H" first="Hisami" last="Ikeda">Hisami Ikeda</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1561F0D665871531FCF0027DC6D3353D8954A606</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1111/j.1537-2995.2005.04320.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-N1N17DR8-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002A65</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002A65</idno>
<idno type="wicri:Area/Istex/Curation">002A65</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D11</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D11</idno>
<idno type="wicri:doubleKey">0041-1132:2005:Morishita K:life:threatening:adverse</idno>
<idno type="wicri:Area/Main/Merge">001E75</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title>
<author><name sortKey="Morishita, Katsuya" sort="Morishita, Katsuya" uniqKey="Morishita K" first="Katsuya" last="Morishita">Katsuya Morishita</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wakamoto, Shinobu" sort="Wakamoto, Shinobu" uniqKey="Wakamoto S" first="Shinobu" last="Wakamoto">Shinobu Wakamoto</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miyazaki, Toru" sort="Miyazaki, Toru" uniqKey="Miyazaki T" first="Toru" last="Miyazaki">Toru Miyazaki</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sato, Shinichiro" sort="Sato, Shinichiro" uniqKey="Sato S" first="Shinichiro" last="Sato">Shinichiro Sato</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fujihara, Mitsuhiro" sort="Fujihara, Mitsuhiro" uniqKey="Fujihara M" first="Mitsuhiro" last="Fujihara">Mitsuhiro Fujihara</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kaneko, Sadao" sort="Kaneko, Sadao" uniqKey="Kaneko S" first="Sadao" last="Kaneko">Sadao Kaneko</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yasuda, Hiroshi" sort="Yasuda, Hiroshi" uniqKey="Yasuda H" first="Hiroshi" last="Yasuda">Hiroshi Yasuda</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yamamoto, Sadamitsu" sort="Yamamoto, Sadamitsu" uniqKey="Yamamoto S" first="Sadamitsu" last="Yamamoto">Sadamitsu Yamamoto</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Azuma, Hiroshi" sort="Azuma, Hiroshi" uniqKey="Azuma H" first="Hiroshi" last="Azuma">Hiroshi Azuma</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Japon</country>
</affiliation>
</author>
<author><name sortKey="Kato, Toshiaki" sort="Kato, Toshiaki" uniqKey="Kato T" first="Toshiaki" last="Kato">Toshiaki Kato</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ikeda, Hisami" sort="Ikeda, Hisami" uniqKey="Ikeda H" first="Hisami" last="Ikeda">Hisami Ikeda</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu</wicri:regionArea>
<wicri:noRegion>Ebetsu</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Transfusion</title>
<title level="j" type="alt">TRANSFUSION</title>
<idno type="ISSN">0041-1132</idno>
<idno type="eISSN">1537-2995</idno>
<imprint><biblScope unit="vol">45</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="803">803</biblScope>
<biblScope unit="page" to="806">806</biblScope>
<biblScope unit="page-count">4</biblScope>
<publisher>Blackwell Science Inc</publisher>
<pubPlace>Oxford, UK and Malden, USA</pubPlace>
<date type="published" when="2005-05">2005-05</date>
</imprint>
<idno type="ISSN">0041-1132</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0041-1132</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adverse effects</term>
<term>Adverse reaction</term>
<term>Adverse reactions</term>
<term>Aggregation</term>
<term>Blood center</term>
<term>Blood components</term>
<term>Blood products</term>
<term>Blood recipients</term>
<term>Blood transfusion</term>
<term>Brain surgery</term>
<term>Case report</term>
<term>Cutaneous manifestation</term>
<term>Cytometric</term>
<term>Flow cytometric analysis</term>
<term>Glycoprotein</term>
<term>Healthy adults</term>
<term>Hiroshi azuma</term>
<term>Ikeda</term>
<term>Isoantibody</term>
<term>Moab</term>
<term>Monocyte</term>
<term>Naka</term>
<term>Negative control</term>
<term>Passive transfusion</term>
<term>Plasma protein</term>
<term>Platelet</term>
<term>Platelet membrane glycoprotein</term>
<term>Plts</term>
<term>Posttransfusion</term>
<term>Posttransfusion syndrome</term>
<term>Rantes</term>
<term>Systolic blood pressure</term>
<term>Thrombocytopenia</term>
<term>Transfusion</term>
<term>Transfusion volume</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND: Anti‐CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura–like syndrome. There are few reports, however, about the effects of passively transfused blood products containing this isoantibody on recipients. CASE REPORT: A 67‐year‐old Japanese woman underwent brain surgery. On the 6th postoperative day, the patient experienced tightness of the chest and nausea after receiving a transfusion of fresh frozen plasma (FFP). When she manifested hypotension, the transfusion was discontinued. No cutaneous manifestation was observed. The patient's condition gradually improved soon after the administration of steroids. RESULTS: Her pretransfusion PLT count was 17.1 × 104 per µL. It decreased to 1.9 × 104 per µL 12 hours after transfusion and recovered to 15.4 × 104 per µL 8 days after transfusion. The donor of the FFP had a Type I CD36 deficiency. Flow cytometric analysis identified anti‐CD36 isoantibody in the FFP. The cross‐match between the patient's PLTs and the FFP was positive. The FFP induced the aggregation of PLTs derived from healthy adults. CONCLUSION: This is the first reported case of life‐threatening adverse effects and thrombocytopenia caused by passively transfused anti‐CD36 isoantibody. The possibility of passive infusion of this antibody should be considered in the evaluation of life‐threatening transfusion reactions followed by thrombocytopenia.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E75 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001E75 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:1561F0D665871531FCF0027DC6D3353D8954A606 |texte= Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |